TG4010 added to chemotherapy vs chemotherapy alone
Progression‐free survival · People with advanced non‐small cell lung cancer
TG4010 added to chemotherapy may leads to lower progression‐free survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
- HR 0.74 [0.55, 0.99]1 study · 222 participantsLow